Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 2
1952 3
1957 1
1959 1
1960 1
1964 1
1965 1
1980 1
1983 1
1989 1
1993 1
1994 1
1995 3
1997 6
1998 2
1999 5
2000 4
2001 8
2002 3
2003 8
2004 10
2005 8
2006 6
2007 15
2008 17
2009 18
2010 15
2011 11
2012 19
2013 11
2014 6
2015 3
2016 9
2017 12
2018 12
2019 9
2020 13
2021 12
2022 7
2023 10
2024 8
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

247 results

Results by year

Filters applied: . Clear all
Page 1
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.
Mirza MR, Chase DM, Slomovitz BM, dePont Christensen R, Novák Z, Black D, Gilbert L, Sharma S, Valabrega G, Landrum LM, Hanker LC, Stuckey A, Boere I, Gold MA, Auranen A, Pothuri B, Cibula D, McCourt C, Raspagliesi F, Shahin MS, Gill SE, Monk BJ, Buscema J, Herzog TJ, Copeland LJ, Tian M, He Z, Stevens S, Zografos E, Coleman RL, Powell MA; RUBY Investigators. Mirza MR, et al. Among authors: gold ma. N Engl J Med. 2023 Jun 8;388(23):2145-2158. doi: 10.1056/NEJMoa2216334. Epub 2023 Mar 27. N Engl J Med. 2023. PMID: 36972026 Clinical Trial.
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
Westin SN, Moore K, Chon HS, Lee JY, Thomes Pepin J, Sundborg M, Shai A, de la Garza J, Nishio S, Gold MA, Wang K, McIntyre K, Tillmanns TD, Blank SV, Liu JH, McCollum M, Contreras Mejia F, Nishikawa T, Pennington K, Novak Z, De Melo AC, Sehouli J, Klasa-Mazurkiewicz D, Papadimitriou C, Gil-Martin M, Brasiuniene B, Donnelly C, Del Rosario PM, Liu X, Van Nieuwenhuysen E; DUO-E Investigators. Westin SN, et al. Among authors: gold ma. J Clin Oncol. 2024 Jan 20;42(3):283-299. doi: 10.1200/JCO.23.02132. Epub 2023 Oct 21. J Clin Oncol. 2024. PMID: 37864337 Free PMC article. Clinical Trial.
Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial.
Powell MA, Bjørge L, Willmott L, Novák Z, Black D, Gilbert L, Sharma S, Valabrega G, Landrum LM, Gropp-Meier M, Stuckey A, Boere I, Gold MA, Segev Y, Gill SE, Gennigens C, Sebastianelli A, Shahin MS, Pothuri B, Monk BJ, Buscema J, Coleman RL, Slomovitz BM, Ring KL, Herzog TJ, Balas MM, Grimshaw M, Stevens S, Lai DW, McCourt C, Mirza MR. Powell MA, et al. Among authors: gold ma. Ann Oncol. 2024 Aug;35(8):728-738. doi: 10.1016/j.annonc.2024.05.546. Epub 2024 Jun 10. Ann Oncol. 2024. PMID: 38866180 Free article. Clinical Trial.
Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39).
Moore KN, Bookman M, Sehouli J, Miller A, Anderson C, Scambia G, Myers T, Taskiran C, Robison K, Mäenpää J, Willmott L, Colombo N, Thomes-Pepin J, Liontos M, Gold MA, Garcia Y, Sharma SK, Darus CJ, Aghajanian C, Okamoto A, Wu X, Safin R, Wu F, Molinero L, Maiya V, Khor VK, Lin YG, Pignata S. Moore KN, et al. Among authors: gold ma. J Clin Oncol. 2021 Jun 10;39(17):1842-1855. doi: 10.1200/JCO.21.00306. Epub 2021 Apr 23. J Clin Oncol. 2021. PMID: 33891472 Free PMC article. Clinical Trial.
Acupuncture in Pediatrics.
Brittner M, Le Pertel N, Gold MA. Brittner M, et al. Among authors: gold ma. Curr Probl Pediatr Adolesc Health Care. 2016 Jun;46(6):179-83. doi: 10.1016/j.cppeds.2015.12.005. Epub 2016 Feb 8. Curr Probl Pediatr Adolesc Health Care. 2016. PMID: 26867822 Review.
Interviewing Adolescents About Sexual Matters.
Pfeffer B, Ellsworth TR, Gold MA. Pfeffer B, et al. Among authors: gold ma. Pediatr Clin North Am. 2017 Apr;64(2):291-304. doi: 10.1016/j.pcl.2016.11.001. Pediatr Clin North Am. 2017. PMID: 28292446 Review.
Emergency contraception.
Conard LA, Gold MA. Conard LA, et al. Among authors: gold ma. Adolesc Med Clin. 2005 Oct;16(3):585-602. doi: 10.1016/j.admecli.2005.06.001. Adolesc Med Clin. 2005. PMID: 16183541
Emergency contraception.
Gold MA. Gold MA. Adv Pediatr. 2000;47:309-34. Adv Pediatr. 2000. PMID: 10959448 Review.
Intrauterine devices and adolescents.
Gold MA, Johnson LM. Gold MA, et al. Curr Opin Obstet Gynecol. 2008 Oct;20(5):464-9. doi: 10.1097/GCO.0b013e32830a98f8. Curr Opin Obstet Gynecol. 2008. PMID: 18797269 Review.
247 results